The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Benzyl-3-(((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)methyl)-amino)benzamide ID: ALA4096791
PubChem CID: 137653406
Max Phase: Preclinical
Molecular Formula: C22H19N5O2
Molecular Weight: 385.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1ccccc1)c1cccc(NCc2nnc(-c3ccncc3)o2)c1
Standard InChI: InChI=1S/C22H19N5O2/c28-21(25-14-16-5-2-1-3-6-16)18-7-4-8-19(13-18)24-15-20-26-27-22(29-20)17-9-11-23-12-10-17/h1-13,24H,14-15H2,(H,25,28)
Standard InChI Key: SVKLMBZNMVZHTI-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
12.9277 -11.2661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2857 -11.7766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4020 -12.5903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1636 -12.8904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8137 -12.3789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6900 -11.5631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5706 -12.6876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8123 -13.4742 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6304 -13.4921 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9016 -12.7200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2477 -12.2159 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6983 -12.4890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2867 -13.0606 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6486 -13.4242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4331 -13.2066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6508 -12.4114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0697 -11.8343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2753 -12.0511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0658 -12.8432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2789 -11.0402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0718 -10.8264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6994 -10.4600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2809 -10.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0738 -9.8144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6538 -10.3964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4460 -10.1832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6558 -9.3883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0714 -8.8069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2814 -9.0233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 1 0
10 12 1 0
12 13 1 0
19 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
13 19 1 0
17 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.43Molecular Weight (Monoisotopic): 385.1539AlogP: 3.67#Rotatable Bonds: 7Polar Surface Area: 92.94Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.44CX LogP: 1.83CX LogD: 1.83Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -1.84
References 1. Okawa T, Aramaki Y, Yamamoto M, Kobayashi T, Fukumoto S, Toyoda Y, Henta T, Hata A, Ikeda S, Kaneko M, Hoffman ID, Sang BC, Zou H, Kawamoto T.. (2017) Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure., 60 (16): [PMID:28699740 ] [10.1021/acs.jmedchem.7b00443 ]